Status:

COMPLETED

Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Miral Operation

Lead Sponsor:

University of Maryland, Baltimore

Collaborating Sponsors:

Edwards Lifesciences

Conditions:

Cardiac Surgery

Tricuspid Valve Regurgitation

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The mitral valve is the inflow valve into the main pumping chamber of the heart. It can become leaky or narrow, and cause blood to back up into the blood vessels of the lungs. When patients get sympto...

Detailed Description

Study Design: This is a single-center prospective, randomized controlled clinical trial. Enroll/Randomize: mitral operation alone, or mitral operation with tricuspid valve repair. Randomization will...

Eligibility Criteria

Inclusion

  • All patients 18-65 + older years undergoing mitral valve surgery.
  • Presence of moderate or mild-moderate tricuspid regurgitation as read on any echocardiographic study performed within 6 months prior to operation. Assessment if tricuspid regurgitation will be performed using an integrative method.
  • All patients referred for mitral valve surgery.
  • Able to understand the consent and able to sign informal consent.

Exclusion

  • Patients under 18 years of age.
  • Patient with structural/ organic tricuspid valve disease.
  • Refusal/ Inability to sign informal consent form.
  • Pregnant women.
  • Tricuspid valve endocarditis.
  • Requirement for concomitant cardiac surgery (other than atrial fibrillation correction surgery, closure of PFO (Patent Foramen Ovale) or ASD (Atrial Septal Defect), or coronary artery bypass surgery).
  • Cardiogenic shock at the time of randomization.
  • ST segment elevation myocardial infarction requiring Intervention within 7 days prior to randomization.
  • Evidence of cirrhosis or hepatic synthetic failure.

Key Trial Info

Start Date :

September 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2017

Estimated Enrollment :

57 Patients enrolled

Trial Details

Trial ID

NCT01246947

Start Date

September 1 2010

End Date

February 1 2017

Last Update

May 8 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Maryland, School of Medicine

Baltimore, Maryland, United States, 21201